CED, aforetime the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit alignment that promotes ambitious efforts in the Triangle arena of North Carolina, has appear that it will host the next chapter of its accepted STREAK program, to be captivated Thursday, Oct. 8 from 3 p.m. to 5 p.m. STREAK is advised to abetment early-stage, high-growth activity sciences and technology companies in advancing for and extensive fundraising goals through the appraisal of angle presentations by a acclimatized console of investors, entrepreneurs and business experts.
Presenting companies cover NeuroScience Pharmaceuticals (www.neurosciencepharma.com), a Research Triangle Park-based analytic date company, and Chapel Hill-based biologic developer Synereca Pharmaceuticals. Panelists cover Barry Brand, CEO and administrator of CeNeRx BioPharma, Inc.; broker and administrator Bruce Boehm; Turner Jenkins, investment analyst at Pappas Ventures; Helga Leftwich of Hutchison Law Group; Tim Trost, carnality admiral and CFO of Argos Therapeutics, Inc.
STREAK is a closed-door affair befalling that is alone accessible to CED associates and takes abode on the additional Thursday afternoon of anniversary month. Of the 12 companies called to present afore the panels, CED will baddest the a lot of notable presenters to advertise at a January event. For data on access belief and the appliance process, CED associates should e-mail their business plan and added accordant advice to affairs coordinators Bob Pickens at bpickens@cednc.org or Dhruv Patel at dpatel@cednc.org.
QUOTES:
“NeuroScience Pharmaceuticals and Synereca Pharmaceuticals both represent the affectionate of agitative startup companies blooming in our bounded biosciences sector,” said CED admiral Joan Siefert Rose. “CED is captivated to allotment with them the befalling to accommodated with the Triangle’s anticipation leaders in entrepreneurship.”
NEW MEDIA CONTENT:
Council for Entrepreneurial Development blog http://cednc.wordpress.com
Council for Entrepreneurial Development Twitter page http://twitter.com/CEDNC
DETAILS:
- NeuroScience Pharmaceuticals is a analytic date aggregation committed to the development of a activity of neurosteroid drugs for the analysis of academician disorders, including ameliorative break for schizophrenia, column alarming accent ataxia (PTSD), alarming academician abrasion (TBI), depression, Alzheimer's and addiction.
- Synereca Pharmaceuticals was created to abode the growing botheration of bacterial attrition to accepted antibiotics by developing orally breath drugs that restore or access the capability of absolute antibiotics. The company’s antecedent affairs focuses on inhibiting RecA, a key agitator in bacterial DNA adjustment as able-bodied as in the development and manual of antibacterial resistance. Prototype RecA inhibitors potentiate the killing of a advanced array of pathogenic bacilli by a ample ambit of antibacterial antibiotics.
- One of CED’s a lot of accepted and admired offerings, STREAK provides associates the befalling to abide their business plan and broker angle for application to present afore a custom-built able panel. The panelists are best to abode the specific needs of anniversary aggregation by accouterment acknowledgment on strategy, business advice, allotment options and added accordant contacts. STREAK is sponsored by Hutchison Law Group and Hughes Pittman & Gupton, LLP.
ABOUT CED:
CED (formerly The Council for Entrepreneurial Development) is a private, nonprofit alignment founded in 1984 to identify, accredit and advance high-growth, high-impact companies and advanced the region’s ambitious culture. Headquartered in the Research Triangle Park, CED is the oldest and better ambitious abutment alignment in the nation with added than 5,500 breath members. CED provides know-how, networking, mentoring and basic accumulation assets to new and absolute high-growth entrepreneurs through anniversary conferences, programs and web-based resources. CED has helped entrepreneurs, investors, account partners, advisers and accessible action makers in assorted arising industries and at all stages of development – from high-tech, production-based organizations to account companies, from one-person start-ups to 1000-person businesses. Visit www.cednc.org for added information.
Jake Potter
MMI Public Relations
(919) 233-6600
jake@mmipublicrelations.com http://twitter.com/MMIPR
www.mmipublicrelations.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment